Source: Eur Respir J 2010; 36: 819-825
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Corte T.J., Wort S.J., Gatzoulis M.A., Engel R., Giannakoulas G., Macdonald P.M., Wells A.U.. Elevated brain natriuretic peptide predicts mortality in interstitial lung disease. Eur Respir J 2010; 36: 819-825

Member's Comments

No comment yet.

Related content which might interest you: Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 The utility of brain natriuretic peptide in patients with stable chronic lung diseases Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 111s Year: 2004 Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Comparison of brain natriuretic peptide to n-terminal pro brain natriuretic peptide in idiopathic interstitial pneumonia Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Prognostic value of serum N-terminal brain natriuretic peptide type B for pulmonary hypertension among patients with usual interstitial pneumonia and sarcoidosis Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases Year: 2007 Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension? Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007 Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2003 Oct 01;22(4):649-653 Year: 2003 Remarkable induction of brain natriuretic peptide in pulmonary emphysema after acute respiratory infection Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 Diffusing lung capacity and pro-brain natriuretic peptide in patients with limited cutaneous form of systemic sclerosis at risk for pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005 Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension Source: Eur Respir J 2010; 35: 95-104 Year: 2010 The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Serum and pleural albumin gradient and brain natriuretic peptide (BNP) levels in the diagnosis of cardiac and non-cardiac pleural effusions Source: Annual Congress 2008 - Pleural effusion Year: 2008 Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Correlation of levels of N-terminal pro-B-type natriuretic peptide with localization of thrombus in acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 The incidence and significance of elevated B-type natriuretic peptide levels in patients hospitalized with apparent respiratory diseases Source: Eur Respir J 2004; 24: Suppl. 48, 279s Year: 2004 Effects of brain natriuretic peptide (BNP) on contractile response in human isolated bronchi Source: Annual Congress 2009 - Translational models of lung disease Year: 2009 N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013